← Stock Trading Canary · All insider profiles
INSIDER PROFILE · BE
Contamine Jérôme
Member of administrative management or supervisory body
Profile key: be|contamine jérôme
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 1
- Purchases · 24M
- 2
- Average purchase
- €37,882
- Gross purchase value
- €75,764
- Last purchase
- 2026-01-22
- Completed 20D events
- 2.0
- Outcome status
- INSUFFICIENT_SAMPLE
Latest company: LAKEFRONT BIOTHERAPEUTICS
Companies: LAKEFRONT BIOTHERAPEUTICS
Post-purchase outcomes
Benchmark-relative outcomes are available against BEL 20.
- Excess return = stock return − BEL 20 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -3.9% | -3.9% | -5.4% |
| 20D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -9.1% | -9.1% | -11.2% |
| 60D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -10.1% | -10.1% | -15.3% |
| 120D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -9.4% | -9.4% | -15.6% |
Research patterns
- First purchase in 12M
- 1/1
- Large purchase ≥ €100k
- 0/2
- Cluster buying · 15D
- 2/2
- Buying the dip · ≥20% below prior 52W high
- 1/2
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.